全文获取类型
收费全文 | 9026篇 |
免费 | 677篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 117篇 |
儿科学 | 135篇 |
妇产科学 | 154篇 |
基础医学 | 1013篇 |
口腔科学 | 221篇 |
临床医学 | 876篇 |
内科学 | 2860篇 |
皮肤病学 | 73篇 |
神经病学 | 524篇 |
特种医学 | 270篇 |
外科学 | 1451篇 |
综合类 | 143篇 |
一般理论 | 3篇 |
预防医学 | 743篇 |
眼科学 | 195篇 |
药学 | 507篇 |
中国医学 | 8篇 |
肿瘤学 | 487篇 |
出版年
2023年 | 99篇 |
2022年 | 122篇 |
2021年 | 314篇 |
2020年 | 147篇 |
2019年 | 273篇 |
2018年 | 344篇 |
2017年 | 190篇 |
2016年 | 195篇 |
2015年 | 244篇 |
2014年 | 351篇 |
2013年 | 427篇 |
2012年 | 682篇 |
2011年 | 714篇 |
2010年 | 422篇 |
2009年 | 345篇 |
2008年 | 540篇 |
2007年 | 614篇 |
2006年 | 506篇 |
2005年 | 510篇 |
2004年 | 489篇 |
2003年 | 426篇 |
2002年 | 370篇 |
2001年 | 84篇 |
2000年 | 77篇 |
1999年 | 75篇 |
1998年 | 76篇 |
1997年 | 83篇 |
1996年 | 45篇 |
1995年 | 43篇 |
1994年 | 39篇 |
1993年 | 42篇 |
1992年 | 57篇 |
1991年 | 51篇 |
1990年 | 49篇 |
1989年 | 39篇 |
1988年 | 42篇 |
1987年 | 46篇 |
1986年 | 43篇 |
1985年 | 38篇 |
1984年 | 34篇 |
1983年 | 26篇 |
1982年 | 36篇 |
1981年 | 29篇 |
1979年 | 25篇 |
1978年 | 29篇 |
1977年 | 25篇 |
1975年 | 23篇 |
1974年 | 23篇 |
1973年 | 23篇 |
1972年 | 22篇 |
排序方式: 共有9780条查询结果,搜索用时 15 毫秒
101.
Jessica Ayers Jamie Cook Rachel A. Koenig Evan M. Sisson Dave L. Dixon 《Current atherosclerosis reports》2018,20(6):29
Purpose of Review
This review examines recent randomized clinical trials evaluating the role of coenzyme Q10 (CoQ10) in the management of coronary heart disease.Recent Findings
CoQ10 is one of the most commonly used dietary supplements in the USA. Due to its antioxidant and anti-inflammatory effects, CoQ10 has been studied extensively for possible use in managing coronary heart disease. One of the most common applications of CoQ10 is to mitigate statin-associated muscle symptoms (SAMS) based on the theory that SAMS are caused by statin depletion of CoQ10 in the muscle. Although previous studies of CoQ10 for SAMS have produced mixed results, CoQ10 appears to be safe. Because CoQ10 is a cofactor in the generation of adenosine triphosphate, supplementation has also recently been studied in patients with heart failure, which is inherently an energy deprived state. The Q-SYMBIO trial found that CoQ10 supplementation in patients with heart failure not only improved functional capacity, but also significantly reduced cardiovascular events and mortality. Despite these positive findings, a larger prospective trial is warranted to support routine use of CoQ10. Less impressive are the effects of CoQ10 on specific cardiovascular risk factors such as blood pressure, dyslipidemia, and glycemic control.Summary
Current evidence does not support routine use of CoQ10 in patients with coronary heart disease. Additional studies are warranted to fully determine the benefit of CoQ10 in patients with heart failure before including it in guideline-directed medical therapy.102.
Cholesterol and mortality in heart failure: the bad gone good? 总被引:6,自引:0,他引:6
103.
Mehta RH Harjai KJ Cox DA Stone GW Brodie BR Boura J Grines L O'Neill W Grines CL;Primary Angioplasty in Myocardial Infarction investigators 《The American journal of cardiology》2005,96(7):901-906
Little is known about the influence of stenting versus balloon angioplasty on long-term outcomes (particularly mortality) after primary percutaneous coronary intervention (PCI). We evaluated 2,087 patients with ST-elevation myocardial infarction enrolled in various Primary Angioplasty in Myocardial Infarction (PAMI) trials in the United States, who underwent primary PCI. The main outcome was all-cause mortality at 5 years, obtained through the National Death Index. Of the 2,087 patients, stenting was performed in 692 (33%). The absolute difference in the hospital (2.2% vs 3.3%), 1-year (3.3% vs 5.2%), and 5-year (10% vs 13%) mortality rates favored patients receiving a stent versus conventional balloon therapy, with the difference increasing with time. A multivariate Cox model identified stent use (vs balloon alone) as an independent correlate of lower 5-year mortality (hazard ratio 0.60, 95% confidence interval 0.42 to 0.85). The absolute reduction in mortality was greatest in the highest risk group. In conclusion, compared with balloon angioplasty, stenting during primary PCI not only resulted in better angiographic and short-term outcomes, but also in a sustained beneficial effect on mortality at 5 years. These data support the routine use of coronary stenting in most patients undergoing primary PCI, when feasible. 相似文献
104.
Guagliumi G Stone GW Cox DA Stuckey T Tcheng JE Turco M Musumeci G Griffin JJ Lansky AJ Mehran R Grines CL Garcia E 《Circulation》2004,110(12):1598-1604
105.
Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence 总被引:13,自引:0,他引:13
OBJECTIVES: Assess the relationship between physical activity and risk for falls and osteoporotic fractures among older adults. DESIGN: Review and synthesis of published literature. MEASUREMENTS: We searched the literature using MEDLINE, Current Contents, and the bibliographies of articles identified. We included randomized controlled trials (RCT) of the effects of physical activity on the incidence of falls and case-control and prospective cohort studies of the association of physical activity with osteoporotic fracture risk. We also summarized mechanisms whereby physical activity may influence risk for falls and fractures. RESULTS: Observational epidemiologic studies and randomized clinical trials evaluating the effectiveness of physical activity programs to prevent falls have been inconclusive. However, many studies have lacked adequate statistical power, and recent trials suggest that exercise, particularly involving balance and lower extremity strength training, may reduce risk of falling. There is consistent evidence from prospective and case-control studies that physical activity is associated with a 20-40% reduced risk of hip fracture relative to sedentary individuals. The few studies that have examined the association between physical activity and risk of other common osteoporotic fractures, such as vertebral and wrist fractures, have not found physical activity to be protective. CONCLUSIONS: Epidemiologic studies suggest that higher levels of leisure time physical activity prevent hip fractures and RCTs suggest certain exercise programs may reduce risk of falls. Future research needs to evaluate the types and quantity of physical activity needed for optimal protection from falls and identify which populations will benefit most from exercise. 相似文献
106.
107.
Chang Joy W. Rubenstein Joel H. Mellinger Jessica L. Kodroff Ellyn Strobel Mary J. Scott Melissa Mack Denise Book Wendy Sable Kathleen Kyle Scholeigh Paliana Allisa Dellon Evan S. 《Digestive diseases and sciences》2021,66(6):1808-1817
Digestive Diseases and Sciences - Little is known about patient choice in treatment of eosinophilic esophagitis (EoE). Determine motivators and barriers to using common EoE therapies and describe... 相似文献
108.
Prasad A Stone GW Aymong E Zimetbaum PJ McLaughlin M Mehran R Garcia E Tcheng JE Cox DA Grines CL Gersh BJ;CADILLAC trial 《American heart journal》2004,147(4):669-675
Background
Age is a strong independent predictor of outcomes after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Whether lower rates of reperfusion success contribute to the poor prognosis in elderly patients is unknown.Methods
A formal ST-segment analysis substudy was performed in 695 patients undergoing primary PCI for AMI in the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Reperfusion success (determined by the magnitude of ST-segment elevation resolution [STR] after PCI) was evaluated in 4 age groups: <50 years (n = 163), ≥50 to <60 years (n = 187), ≥60 to <70 years (n = 194), and ≥70 years (n = 151).Results
There were no differences in the age groups for angiographic procedural success >91% in all, P = .6), postprocedural Thrombolysis in Myocardial Infarction grade 3 flow >94%, P = .8), and the proportions of patients with complete, partial, or absent STR (P >.8). However, rates of 30-day mortality (0.6%, 1.1%, 3.6%, 6.0%, respectively) and major adverse cardiac events (MACE; 2.5%, 4.8%, 6.2% 9.3%, respectively) increased with age. Rates of mortality and MACE were also inversely related to the magnitude of STR. Absent STR (hazard ratio, 3.00; 95% CI, 1.37-6.58; P = .006) and age (hazard ratio, 1.34; 95% CI, 1.01-1.77; P = .04) were independent predictors of 30-day MACE by using multivariable modeling.Conclusions
Lack of effective myocardial reperfusion is not a contributory mechanism responsible for the high morbidity and mortality rates observed in elderly patients. Nevertheless, advanced age and absent STR are both independent predictors of adverse outcomes after primary PCI, emphasizing the importance of successful reperfusion in the elderly population. 相似文献109.
110.
Heather D. Simister Gregg A. Tkachuk Barbara L. Shay Norah Vincent Joseph J. Pear Ryan Q. Skrabek 《The journal of pain》2018,19(7):741-753
In this study, 67 participants (95% female) with fibromyalgia (FM) were randomly assigned to an online acceptance and commitment therapy (online ACT)?and?treatment as usual (TAU; ACT + TAU) protocol or a TAU control condition. Online ACT?+?TAU participants were asked to complete 7 modules over an 8-week period. Assessments were completed at pre-treatment, post-treatment, and 3-month follow-up periods and included measures of FM impact (primary outcome), depression, pain, sleep, 6-minute walk, sit to stand, pain acceptance (primary process variable), mindfulness, cognitive fusion, valued living, kinesiophobia, and pain catastrophizing. The results indicated that online ACT?+?TAU participants significantly improved in FM impact, relative to TAU (P?<.001), with large between condition effect sizes at post-treatment (1.26) and follow-up (1.59). Increases in pain acceptance significantly mediated these improvements (P?=?.005). Significant improvements in favor of online ACT?+?TAU were also found on measures of depression (P?=?.02), pain (P?=?.01), and kinesiophobia (P?=?.001). Although preliminary, this study highlights the potential for online ACT to be an efficacious, accessible, and cost-effective treatment for people with FM and other chronic pain conditions.